Champions Oncology (CSBR) Shares Outstanding (2011 - 2026)

Champions Oncology has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $13.9 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 0.8% year-over-year to $13.9 million in Q2 2026; TTM through Apr 2026 was $13.9 million, a 0.8% increase from a year earlier, with the FY2026 full-year figure at $13.9 million, up 0.8% from the prior year.
• Shares Outstanding (Entity) was $13.9 million for Q2 2026 at Champions Oncology, roughly flat from $13.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $13.9 million in Q1 2026, with the low at $13.5 million in Q3 2023.
• Average Shares Outstanding (Entity) over 5 years is $13.7 million, with a median of $13.6 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) decreased 0.28% in 2023, then grew 1.43% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $13.6 million in 2022, then advanced by 0.26% to $13.6 million in 2023, then grew by 0.77% to $13.7 million in 2024, then grew by 1.37% to $13.9 million in 2025, then increased by 0.0% to $13.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $13.9 million (Q2 2026), $13.9 million (Q1 2026), and $13.9 million (Q4 2025), per Business Quant data.